英文翻译:Started in 1985, Xi'an Janssen, a pharmaceutical subsidiary of Johnson & Johnson in the United States, which owns famous products such as morpholine, dakinin, zele and spireno, is a pharmaceutical subsidiary of Johnson & Johnson and one of the pharmaceutical companies that have entered...
(LEIDEN, Netherlands – September 3, 2019) – The Janssen Pharmaceutical Companies ofJohnson & Johnson(Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for the Comp...
Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson and one of the world’s leaders in oncology, is focused on harnessing the most compelling science with the aim of intercepting, preventing, treating, and ultimately curing cancer. Working toward t...
SOURCE Janssen Pharmaceutical Companies of Johnson & Johnson Europe MORE ON THIS TOPIC Radiopharmaceuticals Sanofi Inks $326M Radiopharma Deal With Orano October 17, 2024 · 2 min read · Tristan Manalac Obesity Lilly’s Sprawling Obesity Clinical Program Undersc...
Significant resources are dedicated to ongoing research and development projects, making Janssen one of the most aggressive pharmaceutical research companies in the world.doi:10.1002/npr.4040120112C. J. McNairKathleen H. J. LeibfriedNational Productivity Review...
At Janssen, we believe transparency of clinical trial data advances science and medicine, and is in the best interest of the patients who use our pharmaceutical products and providers who prescribe them. Media Centre Janssen UK press releases and media resources. ...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration (FDA) seeking approval of Darzalex Faspro (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, for ...
We invite you to visit our sister companies, Janssen Biotech and Janssen Therapeutics, which share in our vision of advancing patient care. Founded in 1985, Xian-Janssen Pharmaceutical Ltd. has since grown into one of China's largest pharmaceutical joint-venture, becoming Johnson & Johnson's larg...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today updated results from the Phase 1b/2 CARTITUDE-1 study (NCT03548207) evaluating the efficacy and safety of JNJ-4528, an investigational B-cell maturation antigen (BCMA)-directed chi
NEW ORLEANS, December 10, 2022– The Janssen Pharmaceutical Companies of Johnson & Johnson announced today updated results from the Phase 1/2 MonumenTAL-1 study of talquetamab, an investigational, off-the-shelf (ready to use), bispecific T-cell engager antibody. Talquetamab ...